Manual Therapy and Splint Therapy in Patients With Temporomandibular Dysfunction

Sponsor
Turkoglu Dr. Kemal Beyazit State Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05352438
Collaborator
(none)
36
1
2
18.2
2

Study Details

Study Description

Brief Summary

The aim of this study was to compare the efficacy of splint treatment and manual therapy in patients diagnosed with myofascial temporomandibular dysfunction with bruxism.

Condition or Disease Intervention/Treatment Phase
  • Other: Manual Therapy Group
  • Other: Splint Therapy Group
N/A

Detailed Description

A total of 56 patients were evaluated. Among those, 20 patients who did not meet the criteria were excluded. 36 patients met the inclusion criteria and were willing to participate in the study.

The patients were randomly separated into two groups using the method of single- and double-digit numbers written on paper in a sealed envelope.

Those who selected a double-digit number were assigned to the manual therapy (MT) group (n:18) and those with a single-digit number to the splint therapy (ST) group (n:18).

After the further exclusion of 7 patients during the treatment period, the final evaluations were compared of 29 patients (15 MT and 14 ST) who completed the 4-week treatment process.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Investigation of the Effectiveness of Manual Therapy and Splint Therapy in Patients With Myofascial Temporomandibular Dysfunction Combined With Bruxism
Actual Study Start Date :
Jan 21, 2019
Actual Primary Completion Date :
Feb 28, 2020
Actual Study Completion Date :
Jul 27, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Manual Therapy Group

Manual Therapy combined with education and home exercises

Other: Manual Therapy Group
Patient education directed at parafunctional behaviors was given, and an exercise program was taught, with all the patients instructed to perform these exercises at home. The home exercise program included diaphragmatic breathing exercises, chin-tuck exercises, mandibular resistance exercises, and neck muscle stretching exercises. The patients were instructed to perform the exercises as 3 sets of 10 repetitions per day. In addition to the patient education and home exercises, the Manual Therapy group received a manual therapy program applied as 2 sessions of 45 mins each week for 4 weeks (total 8 sessions) by an investigator. Soft tissue and joint mobilizations were applied to the TMJ and surrounding structures and to cervical segments, trigger point treatment was applied to trigger points, and myofascial loosening was performed. Patients were instructed to perform the exercises learned in the home exercise program in 3 sets of 10 repetitions every day.

Experimental: Splint Therapy Group

Splint Therapy combined with education and home exercises

Other: Splint Therapy Group
Patient education directed at parafunctional behaviors was given, and an exercise program was taught, with all the patients instructed to perform these exercises at home. The home exercise program included diaphragmatic breathing exercises, chin-tuck exercises, mandibular resistance exercises, and neck muscle stretching exercises. The patients were instructed to perform the exercises as 3 sets of 10 repetitions per day. In addition to the patient education and home exercises, the Splint Therapy group was given a static occlusal splint, and adjustments were made as necessary. All the patients in this group were instructed to use the splint when sleeping for a period of one month.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline in Pain severity at 4 weeks [Baseline, 4 weeks]

    Pain severity was measured with a Visual Analogue Scale (VAS), marked from 0 to 10, where 0 indicates no pain and 10 indicates intolerable pain. The patients were instructed to mark the scale corresponding to the severity of pain felt.

  2. Change frim Baseline in Fatigue severity at 4 weeks [Baseline, 4 weeks]

    Fatigue level was measured with the Fatigue Severity Scale, where patients were asked to indicate their levels of agreement with a 0-7 scale indicating "0" strong disagreement and "7" strong agreement at a total of 9 questions. A sum of all responses was calculated for analysis. Sixty-three was the maximum score. The higher value represented a higher level of fatigue.

  3. Change from Baseline in Sleep quality at 4 weeks [Baseline, 4 weeks]

    The sleep quality of patients was analyzed with the Pittsburgh Sleep Quality Index (PSQI). The PSQI includes 24 items related to both daytime and nocturnal sleep. The responses were scored from 0-3, as 7 subscores to give a global score of total points in the range of 0-21. A score of ≥5 indicated poor sleep quality.

  4. Change from Baseline in Jaw Function limitation at 4 weeks [Baseline, 4 weeks]

    Jaw function limitation was measured by the Jaw Functional Limitation Scale-20 (JFLS-20) where the patients asked for from 1 to 10 points per item (higher scores indicate worse jaw function). The JFLS-20 has 3 subscales: Mastication (6 items), Vertical Jaw Mobility (4 items), and Emotional and Verbal Expression (10 items).

  5. Change from Baseline in Neck Disability at 4 weeks [Baseline, 4 weeks]

    Neck Disability Index, consists of 10 items. Individuals included in the study were asked to give a score between 0 (no disability) and 5 (complete disability) for each item. The total score varies between 0 (no disability) and 50 (complete disability).

  6. Change from Baseline in Patient Satisfaction questionnaire at 4 weeks. [Baseline, 4 weeks]

    The Patient Satisfaction questionnaire was used to assess the patient's satisfaction with the treatment received. The patient satisfaction questionnaire (PSQ) contains 18 items tapping each of the seven dimensions of satisfaction with medical care measured by the PSQ-18.

  7. Change from Baseline in Headache severity at 4 weeks [Baseline, 4 weeks]

    The Headache Impact Test-6 (HIT-6) was used to assess the headache. The 6-item scale evaluates the frequency, the degree of restriction to daily life and social life, and changes in the mood. The total score of 50-59 reflects the important impact, and scores ≥60 indicate severe impact.

Secondary Outcome Measures

  1. Change from Baseline in Head Posture at 4 weeks [Baseline, 4 weeks]

    Head posture is defined as the craniovertebral angle. It is the angle formed by the intersection of a horizontal line along the spinous process of C7 and the line drawn towards the ear tragus. A craniovertebral angle of <48-50° is accepted as an anterior tilt of the head.

  2. Change from Baseline in Cervical Range of Motion at 4 weeks [Baseline, 4 weeks]

    A goniometer was used to measure the cervical region's range of motion (ROM). Cervical region flexion, extension, right-left lateral flexion, and right-left rotation degrees were measured and recorded.

  3. Change from Baseline in Temporomandibular Joint Range of Motion at 4 weeks [Baseline, 4 weeks]

    For maximal mouth opening, the distance between the upper and lower incisors was measured and recorded. For protrusion, the distance between the lower and upper incisors was measured horizontally by asking the patient to bring the lower jaw forward as far as possible while the posterior teeth were in contact with each other. For right and left lateral shifts, the distance between the upper and lower incisors was measured by asking the patient to slide it to the right and left separately as much as possible.

  4. Change from Baseline in Trigger points at 4 weeks [Baseline, 4 weeks]

    While the participants were in the supine position the masseter, temporalis, pyterigoideus lateralis, pyterigoideus medialis, and digastric muscles were evaluated. In the sitting position, the sternoclavicular, suboccipital, and upper trapezius muscles were palpated, and the trigger points in these muscles and their number were evaluated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ages between 18 and 50 years old,

  • Patients with a diagnosis of myofascial TMD with Bruxism according to the diagnostic criteria for temporomandibular disorders (DC/TMD),

  • Having pain severity ≥3 according to the Visual analogue scale (VAS),

  • Probable sleep bruxism according to clinical evaluation and a questionnaire-based assessment.

Exclusion Criteria:
  • Patients with a diagnosis other than myofascial TMD according to the research DC/TMD,

  • a history of surgery associated with cervical and/or TMJ problems,

  • a proven specific pathological condition such as cervical and/or TMJ malignancy, fracture, or systemic rheumatoid disease,

  • a history of facial paralysis, a diagnosed psychiatric disease,

  • if they were undergoing orthodontic treatment,

  • had received physiotherapy within the last 3 months,

  • or could not be co-operative.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Türkoğlu Dr. Kemal Beyazıt State Hospital Kahramanmaraş Turkey

Sponsors and Collaborators

  • Turkoglu Dr. Kemal Beyazit State Hospital

Investigators

  • Study Director: Aysenur Tuncer, Hasan Kalyoncu University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Süreyya DAMAR ÖRENLER, Principal Investigator, Turkoglu Dr. Kemal Beyazit State Hospital
ClinicalTrials.gov Identifier:
NCT05352438
Other Study ID Numbers:
  • 2019-67
First Posted:
Apr 28, 2022
Last Update Posted:
Apr 28, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Süreyya DAMAR ÖRENLER, Principal Investigator, Turkoglu Dr. Kemal Beyazit State Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2022